Searchable abstracts of presentations at key conferences in endocrinology

ea0013oc22 | Novartis Basic Endocrinology Award | SFEBES2007

Mice deleted for a Multiple Endocrine Neoplasia Type 1 (MEN1) allele develop pancreatic, pituitary and parathyroid tumours in association with hypercalcaemia

Lemos Manuel , Harding Brian , Bowl Michael , Reed Anita , Tateossian Hilda , Hough Tertius , Fraser William , Cheeseman Michael , Thakker Rajesh

Multiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by the combined occurrence of tumours of the parathyroids, pancreas and pituitary. The MEN1 gene, which is located on chromosome 11q13 and encodes a 610 amino acid protein (menin), belongs to the class of tumour suppressors. To investigate the role of menin in tumour suppression, three different mouse models have been generated through targeted disruption of the Men1 gene. ...

ea0013p149 | Diabetes, metabolism and cardiovascular | SFEBES2007

Metabolic cage studies reveal that mice require 5 days for acclimatisation: establishing normal urinary and blood biochemistry values in BALB/c and C3H/HeH inbred mouse strains

Stechman Michael , Ahmad Bushra , Loh Nellie , Reed Anita , Hough Tertius , Bentley Liz , Cox Roger , Brown Steve , Thakker Rajesh

Inbred laboratory mice are widely used to generate, by homologous recombination, transgenic and chemical mutagenesis routes, genetic models of human disease. However, physiological studies of such models are hampered by the lack of normal ranges for serum and urinary biochemistry, particularly in relation to acclimatisation following placement in metabolic cages. To establish such values, we investigated urinary and serum parameters in forty, 24–30 week-old C3H/HeH, BALB/...

ea0058p080 | Diabetes | BSPED2018

Optimal use of resources and teamwork improves glycaemic control in a multi-ethnic population-Evidence from the National Paediatric Diabetes Audit (NPDA)

Nambisan Aparna K R , Fuller Fionnghuala , Reed Charlotte , Owens Mary , Digkliou Lila , O'Bierne Caroline , Jean-Jacques Davina , Boyaram Shannon , Kapila Piyusha

Introduction: Patients who have diabetes are at risk of complications, both acutely and in the long term. Although care is individualised, it may not be practical to continuously review this on an individual basis. An audit evaluating outcomes is a useful tool to reflect on multidisciplinary team management. We describe how effective use of resources led to better results in a multi-ethnic population.Population: A total of 130 children and young people w...

ea0034oc5.1 | Pituitary | SFEBES2014

Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 allele and null for prolyl hydroxylase domain protein 1 (Men1+/−/Phd1−/−)

Stevenson Mark , Piret Sian , Javid Mahsa , Bishop Tammie , Reed Anita , Walls Gerard , Gaynor Katie , Newey Paul , Christie Paul , Nicholls Lynn , Ratcliffe Peter , Thakker Rajesh

Cumulative genetic abnormalities within an oncogenic pathway may contribute to earlier onset or increased aggressiveness of cancers. An example in human and murine cancer is the dysregulation of Wnt signalling by inactivation of the adenomatous polyposis coli (APC) gene that results in accumulation of nuclear β-catenin and earlier onset of renal cell carcinoma, which can be accelerated by p53-deficiency. We therefore investigated the effects of such cumulative genetic abn...

ea0031oc5.1 | Pituitary and neoplasia | SFEBES2013

Genetic background influences tumour phenotype in heterozygous Men1 knockout mice

Lines Kate E , Javid Mahsa , Reed Anita A C , Piret Sian E , Walls Gerard V , Stevenson Mark , Christie Paul T , Thakker Rajesh V

Multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder characterised by the occurrence of parathyroid, pancreatic islet and anterior pituitary tumours, is due to mutations of a tumour suppressor gene, MEN1. MEN1 mutations have also been reported to cause familial isolated primary hyperparathyroidism (FIHP). Moreover, 15 identical MEN1 mutations have been reported to cause MEN1 or FIHP in unrelated families; thereby implicating a r...

ea0021p19 | Bone | SFEBES2009

Hereditary renal calcification locus, Rcalc1, is associated with altered expression of cell survival genes

Loh Nellie Y , Stechman Michael J , Schulz Herbert , Jeyabalan Jeshmi , Reed Anita A C , Ahmad Bushra , Stewart Michelle , Brown Steve D M , Huebner Norbert , V. Thakker Rajesh

Renal stone disease is a common disorder for which the underlying causes remain largely unknown. We have investigated a hereditary renal calcification mouse model, Rcalc1, that is not associated with hypercalciuria for underlying mechanisms. Kidney RNA from 30 to 33 week-old Rcalc1 and control BALB/c and C3H female mice (n=4/group) was extracted and hybridised to Mouse Genome 430 2.0 arrays (Affymetrix). Following Robust Multichip Average normalization, pair-wise compar...

ea0019oc30 | Bone and Calcium | SFEBES2009

Mice deleted for the hyperparathyroidism-jaw tumour (HPT-JT) syndrome allele have abnormal parathyroids with increased proliferation rates

Walls G , Bowl M , Jeyabalan J , Reed A , Harding B , Ali A , Bradley K , Wang P , Chen J , Williams B , Teh B , Thakker R

The hyperparathyroidism-jaw tumour (HPT-JT) syndrome, an autosomal dominant disorder, is characterised by the occurrence of parathyroid tumours, often carcinomas, and ossifying fibromata of the jaw. The HPT-JT gene, referred to as HRPT2, is located on chromosome 1q25 and consists of 17 exons that encode a 531 amino-acid protein designated parafibromin. To explore the role of HRPT2 in parathyroid tumourigenesis, we generated two mouse models that comprised a conve...

ea0015p191 | Endocrine tumours and neoplasia | SFEBES2008

In vivo delivery of an adenoviral gene therapy vector to pituitary tumours in Men1 deficient mice

Lemos Manuel , Harding Brian , Reed Anita , Walls Gerard , Tyler Damian , Bazan-Peregrino Miriam , Ansorge Olaf , Clarke Kieran , Seymour Len , Thakker Rajesh

The mouse knockout model for multiple endocrine neoplasia type 1 (MEN1) closely resembles the phenotype of the human disorder, with frequent development of tumours of the parathyroids, pancreas and pituitary. These tumours have loss of heterozygosity (LOH) of the Men1 locus and lack expression of the encoded protein (menin).The aim of this study was to investigate the feasibility of detecting pituitary tumours in heterozygous (Men1+/−...

ea0013p140 | Diabetes, metabolism and cardiovascular | SFEBES2007

cDNA expression profiling studies reveal 7 differentially expressed genes on mouse chromosome 7 that may influence renal calcification in C3H/HeH inbred mice

Loh Nellie , Stechman Michael , Reed Anita , Ahmad Bushra , Stewart Michelle , Hacker Terry , Schulz Herbert , Born Gabi , Dear Neil , Brown Steve , Hubner Norbert , Thakker Rajesh

Vascular calcification, occurring in organs such as heart and kidneys, is associated with increased risk of cardiovascular mortality. The underlying molecular mechanisms remain unknown. To elucidate these, we investigated C3H mice, an inbred strain susceptible to vascular, myocardial and renal calcification. Myocardial calcification in C3H mice involves 4 genetic loci, Dyscalc1-4, that map to chromosomes 7, 4, 12 and 14, respectively. Dyscalc1 contributes to myoc...

ea0011p433 | Endocrine disruptors | ECE2006

A randomized, open-label, multicenter study to evaluate octreotide LAR with surgical therapy as primary therapy patients with acromegaly

Colao A , Bouterfa H , Cappabianca P , Caron P , De Menis E , Farrall A , Gadelha M , Reed A , Reincke M , Safari M , T’Sjoen G , Cuneo R

This is the first prospective study to compare the efficacy and safety of medical therapy and surgery as primary therapy in acromegaly.A total of 104 patients with untreated acromegaly were enrolled. Eighty-one patients randomized to receive either octreotide LAR 20 mg (n=40) or surgery (n=41) completed the 48 weeks treatment period, and constituted the population used for this analysis, regardless of response to treatment.<p class="abs...